Page last updated: 2024-08-26

phorbolol myristate acetate and e-z cinnamic acid

phorbolol myristate acetate has been researched along with e-z cinnamic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YL; Chiang, YL; Lu, SH; Sun, FM; Weng, CJ; Yen, GC1
Chen, YL; Hsu, CL; Sun, FM; Tsai, CM; Weng, CJ; Yen, GC1

Other Studies

2 other study(ies) available for phorbolol myristate acetate and e-z cinnamic acid

ArticleYear
A comparative study on the effectiveness of cis- and trans-form of cinnamic acid treatments for inhibiting invasive activity of human lung adenocarcinoma cells.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Oct-09, Volume: 44, Issue:3

    Topics: Antineoplastic Agents; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatography, High Pressure Liquid; Cinnamates; Dose-Response Relationship, Drug; Drug Stability; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Biological; Neoplasm Invasiveness; Stereoisomerism; Tetradecanoylphorbol Acetate

2011
Molecular mechanism depressing PMA-induced invasive behaviors in human lung adenocarcinoma cells by cis- and trans-cinnamic acid.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Feb-14, Volume: 48, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carcinogens; Cell Line, Tumor; Cinnamates; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Biological; Neoplasm Invasiveness; Neoplasm Proteins; Osmolar Concentration; Stereoisomerism; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Urokinase-Type Plasminogen Activator

2013